Anaesthetics and postoperative cognitive dysfunction: A pathological mechanism mimicking Alzheimer's disease: Review article

Anaesthesia

Volumn 65, Issue 4, 2010, Pages 388-395

  Fodale, V ^c   Santamaria, L B ^c   Schifilliti, D ^a   Mandal, P K ^b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NATIONAL BRAIN RESEARCH CENTRE   (India)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMYLOID; AMYLOID BETA PROTEIN[25-35]; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; ATROPINE; BARBITURIC ACID DERIVATIVE; CHOLINE ACETYLTRANSFERASE; DESFLURANE; DIAZEPAM; FENTANYL; FOCAL ADHESION KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOTHANE; INTERLEUKIN 18; ISOFLURANE; KETAMINE; MITOGEN ACTIVATED PROTEIN KINASE; MORPHINE; MUSCARINIC RECEPTOR; NEOSTIGMINE; NEUROMUSCULAR BLOCKING AGENT; PHYSOSTIGMINE; PROPOFOL; PROTEIN TYROSINE KINASE; REMIFENTANIL; SEVOFLURANE; STRESS ACTIVATED PROTEIN KINASE; THIOPENTAL; THYROID HORMONE;

ACETYLCHOLINE RELEASE; AGE; AGITATION; ALZHEIMER DISEASE; AMNESIA; ANALGESIA; ANXIETY; BODY TEMPERATURE; BRAIN; BRAIN CELL; BRAIN SIZE; CALCIUM TRANSPORT; CARDIOPULMONARY BYPASS; CELL DEATH; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHOLINERGIC SYNAPSE; COGNITION; COGNITIVE DEFECT; CONFUSION; DELIRIUM; DELUSION; DEPENDENT PERSONALITY DISORDER; DEPRESSION; DISORIENTATION; DNA POLYMORPHISM; EDUCATION; FOREBRAIN; GENE EXPRESSION; GENERAL ANESTHESIA; HIPPOCAMPUS; HUMAN; HUNTINGTON CHOREA; HYPERTENSION; HYPERVENTILATION; HYPOTENSION; HYPOXIA; IN VITRO STUDY; INCIDENCE; INSOMNIA; MEAN ARTERIAL PRESSURE; MICROEMBOLISM; NEOCORTEX; NERVE DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NOCICEPTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLIGOMERIZATION; ORTHOPEDIC SURGERY; OXYGEN SATURATION; PATHOGENESIS; PHEOCHROMOCYTOMA CELL; POSTOPERATIVE COMPLICATION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; QUALITY OF LIFE; REGIONAL ANESTHESIA; REVIEW;

AGE FACTORS; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANESTHETICS; APOPTOSIS; COGNITION DISORDERS; HUMANS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 77949694155     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2010.06244.x     Document Type: Review

References (72)

1. Culley DJ, Baxter M, Yukhananov R, Crosby G. The memory effects of general anesthesia persist for weeks in young and aged rats. Anesthesia and Analgesia 2003 96 : 1004 1009.
2. Perouansky M. General anesthetics and long-term neurotoxicity. Handbook of Experimental Pharmacology 2008 182 : 147 157.
3. Perouansky M. Liaisons dangereuses? General anaesthetics and long-term toxicity in the CNS. European Journal of Anaesthesiology 2007 24 : 107 115.
4. Flacker JM, Lipsitz LA. Neural mechanisms of delirium: current hypotheses and evolving concepts. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 1999 54 : B275.
5. Mandal PK, Schifilliti D, Mafrica F, Fodale V. Inhaled anesthesia and cognitive performance. Drugs of Today 2009 45 : 47 54.
6. Seymour DG, Severn AM. Cognitive dysfunction after surgery and anesthesia: what can we tell the grandparents? Age and Ageing 2009 38 : 147 150.
7. Moller JT, Cluitmans P, Rasmussen LS. Long-term postoperative cognitive dysfunction in the elderly ISPOCD1 study: ISPOCD investigators - International Study of Post-Operative Cognitive Dysfunction. The Lancet 1998 351 : 857 861.
8. Mrak RE, Griffin ST, Graham DI. Aging-associated changes in human brain. Journal of Neuropathology and Experimental Neurology 1997 56 : 1269 1275.
9. Raja PV, Blumenthal JA, Doraiswamy P. Cognitive deficits following coronary artery bypass grafting: prevalence, prognosis, and therapeutic strategies. CNS Spectrums 2004 9 : 763 772.
10. Butterfield NN, Graf P, Ries CR, MacLeod BA. The effect of repeated isoflurane anesthesia on spatial and psychomotor performance in young and aged mice. Anesthesia and Analgesia 2004 98 : 1305 1311.
11. Ahlgren E, Lundqvist A, Nordlund A, Aren C, Rutberg H. Neurocognitive impairment and driving performance after coronary artery bypass surgery. European Journal of Cardio-Thoracic Surgery 2003 23 : 334 340.
12. Verborgh C. Anesthesia in patients with dementia. Current Opinion in Anesthesiology 2004 17 : 277 283.
13. Lundstrom M, Edlund A, Karlsson S, Brannstrom B, Bucht G, Gustafson Y. A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. Journal of the American Geriatrics Society 2005 53 : 622 628.
14. Steinmetz J, Christensen KB, Lund T, Lohse N, Rasmussen LS, ISPOCD Group. Long-term consequences of postoperative cognitive dysfunction. Anesthesiology 2009 110 : 548 555.
15. Yildizeli B, Ozyurtkan MO, Batirel HF. Factors associated with postoperative delirium after thoracic surgery. The Annals of Thoracic Surgery 2005 79 : 1004 1009.
16. Morimoto Y, Yoshimura M, Utada K, Setoyama K, Matsumoto M, Sakabe T. Prediction of postoperative delirium after abdominal surgery in the elderly. Journal of Anesthesia 2009 23 : 51 6.
17. Davenport HT. Anaesthetics and elderly patients. British Medical Journal 1991 303 : 870 871.
18. Selwood A, Orrell M. Long term cognitive dysfunction in older people after non-cardiac surgery. British Medical Journal 2004 328 : 120 121.
19. Lewis M, Maruff P, Silbert B. Statistical and conceptual issues in defining post-operative cognitive dysfunction. Neuroscience and Biobehavioral Reviews 2004 28 : 433 440.
20. Canet J, Raeder J, Rasmussen LS, et al. ISPOCD2 investigators. Cognitive dysfunction after minor surgery in the elderly. Acta Anaesthesiologica Scandinavica 2003 47 : 1204 1210.
21. Kagansky N, Rimon E, Naor S, Dvornikov E, Cojocaru L, Levy S. Low incidence of delirium in very old patients after surgery for hip fractures. The American Journal of Geriatric Psychiatry 2004 12 : 306 314.
22. Yoshitani K, Ohnishi Y. Cognitive dysfunction after cardiac surgery. Masui 2009 58 : 308 314.
23. Pandit JJ, Pigott D. Cognitive dysfunction after cardiac surgery: strategies for prevention. British Journal of Cardiology 2001 8 : 613 616.
24. McKhann GM, Borowicz LM, Goldsborough MA, Enger C, Selnes OA. Depression and cognitive decline after coronary artery bypass grafting. The Lancet 1997 349 : 1282 1284.
25. Diegeler A, Hirsch A, Schneider F, et al. Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation. The Annals of Thoracic Surgery 2000 69 : 1162 1166.
26. Newman MF, Croughwell ND, Blumenthal JA, et al. Predictors of cognitive decline after cardiac operation. The Annals of Thoracic Surgery 1995 59 : 1326 1330.
27. Merkouris A, Apostolakis E, Pistolas D, Papagiannaki V, Diakomopoulou E, Patiraki E. Quality of life after coronary artery bypass graft surgery in the elderly. European Journal of Cardiovascular Nursing 2009 8 : 74 81.
28. Roses AD, Saunders AM. ApoE, Alzheimer's disease, and recovery from brain stress. Annals of the New York Academy of Sciences 1997 826 : 200 212.
29. Felderhoff-Mueser U, Schmidt OI, Oberholzer A, Buhrer C, Stahel PF. IL-18: a key player in neuroinflammation and neurodegeneration? Trends in Neurosciences 2005 28 : 487 493.
30. Dinarello CA. Interleukin 1 and interleukin 18 as mediators of inflammation and the aging process. The American Journal of Clinical Nutrition 2006 83 : 447S 55S.
31. Laalou FZ, Carre AC, Forestier C, Sellal F, Langeron O, Pain L. Pathophysiology of post-operative cognitive dysfunction: current hypotheses. Journal de Chirurgie 2008 145 : 323 330.
32. Praticò C, Quattrone D, Lucanto T, et al. Drugs of anesthesia acting on central cholinergic system may cause post-operative cognitive dysfunction and delirium. Medical Hypotheses 2005 65 : 972 982.
33. Yocum GT, Gaudet JG, Teverbaugh LA, et al. Neurocognitive performance in hypertensive patients after spine surgery. Anesthesiology 2009 110 : 254 261.
34. Mafrica F, Fodale V. Thryoid function, Alzheimer's disease and postoperative cognitive dysfunction: a tale of dangerous liaisons? Journal of Alzheimer's Disease 2008 14 : 95 105.
35. Amenta F, Parnetti L, Gallai V, Wallin A. Treatment of cholinergic dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches? Mechanisms of Ageing and Development 2001 122 : 2025 2040.
36. Gauthier S. Advances in the pharmacotherapy of Alzheimer's disease. Canadian Medical Association Journal 2002 166 : 616 623.
37. Graham AJ, Martin-Ruiz CM, Teaktong T, Ray MA, Court JA. Human brain nicotinic receptors, their distribution and participation in neuropsychiatric disorders. Current Drug Targets Central Nervous System and Neurological Disorders 2002 1 : 387 397.
38. Fodale V, Santamaria LB. Drugs of anesthesia, central nicotinic receptors and post-operative cognitive dysfunction. Acta Anaesthesiologica Scandinavica 2003 47 : 1180 1182.
39. Fodale V, Praticò C, Santamaria LB. Drugs of anesthesia, central nicotinic receptors and Parkinson's disease. Parkinsonism & Related Disorders 2004 10 : 189 190.
40. Fodale V, Praticò C, Santamaria LB. Potential neuroprotective properties of atracurium and cisatracurium in neurosurgical anaesthesia. European Journal of Anaesthesiology 2004 21 : 333 334.
41. Liu Q, Wu J. Neuronal nicotinic acetylcholine receptors serve as sensitive targets that mediate beta-amyloid neurotoxicity. Acta Pharmacologica Sinica 2006 27 : 1277 1286.
42. Rubio A, Perez M, Avila J. Acetylcholine receptors and tau phosphorylation. Current Molecular Medicine 2006 6 : 423 428.
43. Kar S, Slowikowski SPM, Westaway D, Mount HTJ. Interactions between β-amyloid and central cholinergic neurons: implications for Alzheimer's disease. Journal of Psychiatry & Neuroscience 2004 29 : 427 441.
44. Fodale V, Quattrone D, Trecroci C, Caminiti V, Santamaria LB. Alzheimer's disease and anaesthesia: implications for the central cholinergic system. British Journal of Anaesthesia 2006 97 : 445 452.
45. Hellstrom-Lindahl E. Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors. European Journal of Pharmacology 2000 393 : 255 263.
46. Lenzken SC, Lanni C, Govoni S, Lucchelli A, Schettini G, Racchi M. Nicotinic component of galantamine in the regulation of amyloid precursor protein processing. Chemico Biological Interactions 2007 165 : 138 145.
47. Nabeshima T, Nitta A. Memory impairment and neuronal dysfunction induced by beta-amyloid protein in rats. The Tohoku Journal of Experimental Medicine 1994 174 : 241 249.
48. Yamada K, Tanaka T, Mamiya T, Shiotani T, Kameyama T, Nabeshima T. Improvement by nefiracetam of beta-amyloid-(1-42)-induced learning and memory impairments in rats. British Journal of Pharmacology 1999 126 : 235 244.
49. Xie Z, Tanzi RE. Alzheimer's disease and post-operative cognitive dysfunction. Experimental Gerontology 2006 41 : 346 359.
50. Nordberg A. Neuroprotection in Alzheimer's disease - new strategies for treatment. Neurotoxicity Research 2000 2 : 157 165.
51. Weiss C, Venkatasubramanian PN, Aguado AS, et al. Impaired eyeblink conditioning and decreased hippocampal volume in PDAPP V717F mice. Neurobiology of Disease 2002 11 : 425 433.
52. Xie Z, Culley DJ, Dong Y, et al. The common inhalational anesthetic isoflurane induces caspase activation and increases amyloid beta-protein level in vivo. Annals of Neurology 2008 64 : 618 627.
53. Xie Z, Dong Y, Maeda U, et al. The common inhalation anesthetic isoflurane induces apoptosis and increases amyloid beta protein levels. Anesthesiology 2006 104 : 988 994.
54. Zhang B, Dong Y, Zhang G, et al. The inhalation anesthetic desflurane induces caspase activation and increases amyloid beta-protein levels under hypoxic conditions. Journal of Biological Chemistry 2008 283 : 11866 11875.
55. Palotas M, Palotas A, Bjelik A, et al. Effect of general anesthetics on amyloid precursor protein and mRNA levels in the rat brain. Neurochemical Research 2005 30 : 1021 1026.
56. Eckenhoff RG, Johansson JS, Wei H, et al. Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity. Anesthesiology 2004 101 : 703 709.
57. Mandal PK, Pettegrew JW. Abeta peptide interactions with isoflurane, propofol, thiopental and combined thiopental with halothane: a NMR study. Biochimica et Biophysica Acta 2008 1778 : 2633 2639.
58. Bissette G. Mini-Forum: roles of Amyloid-beta and Tau Phosphorylation in Neuronal Repair and Protection. Journal of Alzheimer's Disease 2009 18 : 369 370.
59. Pavia J, de Ceballos ML, Sanchez de la Cuesta F. Alzheimer's disease: relationship between muscarinic cholinergic receptors, beta-amyloid and tau proteins. Fundamental and Clinical Pharmacology 1998 12 : 473 481.
60. Fodale V, Santamaria LB. The inhibition of central nicotinic nAch receptors is the possible cause of prolonged cognitive impairment after anesthesia. Anesthesia and Analgesia 2003 97 : 1207.
61. Qiu Y, Wu XJ, Chen HZ. Simultaneous changes in secretory amyloid precursor protein and beta-amyloid peptide release from rat hippocampus by activation of muscarinic receptors. Neuroscience Letters 2003 352 : 41 4.
62. Fodale V, Schifilliti D, Praticò C, Santamaria LB. Remifentanil and the brain. Acta Anaesthesiologica Scandinavica 2008 52 : 319 326.
63. Yoon MH, Choi JI, Jeong SW. Antinociception of intrathecal cholinesterase inhibitors and cholinergic receptors in rats. Acta Anaesthesiologica Scandinavica 2003 47 : 1079 1084.
64. Laalou FZ, De Vasconcelos AP, Oberling P, Jeltsch H, Cassel JC, Pain L. Involvement of the basal cholinergic forebrain in the mediation of general (propofol) anesthesia. Anesthesiology 2008 108 : 888 896.
65. Xie Z, Dong Y, Maeda U, et al. The inhalation anesthetic isoflurane induces a vicious cycle of apoptosis and amyloid beta-protein accumulation. Journal of Neuroscience 2007 27 : 1247 1254.
66. Wei H, Liang G, Yang H, et al. The common inhalational anesthetic isoflurane induces apoptosis via activation of inositol 1,4,5-trisphosphate receptors. Anesthesiology 2008 108 : 251 260.
67. Zhang G, Dong Y, Zhang B, et al. Isoflurane-induced caspase-3 activation is dependent on cytosolic calcium and can be attenuated by memantine. The Journal of Neuroscience 2008 28 : 4551 4560.
68. Charles E, Bouby-Serieys V, Thomas P, Clement JP. Links between life events, traumatism and dementia; an open study including 565 patients with dementia. L'Encephale 2006 32 : 746 752.
69. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. The Lancet 2006 368 : 387 403.
70. Hardy J, Selko DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002 297 : 353 356.
71. Mandal PK, Fodale V. Isoflurane and desflurane at clinically relevant concentrations induce amyloid beta-peptide oligomerization: an NMR study. Biochemical and Biophysical Research Communications 2009 379 : 716 720.
72. Mandal PK, Fodale V. Smaller molecular-sized anaesthetics oligomerize Abeta peptide simulating Alzheimer's disease: a relevant issue. European Journal of Anaesthesiology 2009 26 : 805 806.